Cefazolin for Injection USP and Dextrose Injection USP, 2 g in Duplex, 50 mL Container, Catalog ...

FDA Recall #D-1269-2014 — Class I — November 21, 2013

Recall #D-1269-2014 Date: November 21, 2013 Classification: Class I Status: Terminated

Product Description

Cefazolin for Injection USP and Dextrose Injection USP, 2 g in Duplex, 50 mL Container, Catalog Number 3105-11, Rx Only, B Braun Medical Inc., Irvine CA 92614, NDC 0264-3105-11

Reason for Recall

Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.

Recalling Firm

B. Braun Medical Inc — Irvine, CA

Classification

Class I — Reasonable probability of serious adverse health consequences or death.

Product Type

Drugs

Product Quantity

42,576 units

Distribution

Nationwide, Puerto Rico and Spain

Code Information

Lot# H2S723, Exp 07/14; H3H711, Exp 01/15

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated